Jump to content

Paul Stoffels

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Magioladitis (talk | contribs) at 20:05, 30 July 2016 (clean up / fix section header naming (WP:ASL) using AWB (12061)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Paul Stoffels (born 8 March 1962 in Turnhout, Belgium) is a Belgian MD, who studied Medicine at the University of Hasselt and the University of Antwerp (UA). In addition he studied Infectious Diseases and Tropical Medicine at the Prince Leopold Institute of Tropical Medicine in Antwerp, Belgium.

Career

Stoffels worked for 4 years as a physician and researcher of HIV/AIDS in Africa, where he met Peter Piot. In 1991, he returned to Belgium and became the Head of Development for the HIV compounds at Janssen Pharmaceutica in Beerse, Belgium. In 1993 he was promoted to Director of Clinical Research and Development for Infectious Diseases and Dermatology. In 1997, he left Janssen Pharmaceutica and together with Rudi Pauwels co-founded the biotech companies Tibotec and Virco. When Johnson & Johnson acquired Tibotec-Virco in April 2002, he became Company Group Chairman of the Global Virology Franchise at Johnson & Johnson and Chairman of Tibotec. Currently Stoffels is Chairman of the pharmaceutical group at Johnson&Johnson.

See also

Sources

External links


Flag of BelgiumScientist icon Stub icon

This article about a Belgian scientist is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Paul_Stoffels&oldid=732271364"